January 23, 2018 PR-M01-18-NI-076
BRISTOL, Tenn., Jan. 19, 2018 /PRNewswire/ — UPM Pharmaceuticals, a Contract Development and Manufacturing Organization (CDMO) focused on solid oral and semi-solid dosage forms, has appointed Chris Curtin as Chief Operating Officer. Mr. Curtin was promoted from his previous role as Executive Vice President of Quality Operations. Mr. Curtin will lead the organization responsible for Research & Development, Manufacturing, Quality Assurance, Inventory Management, Quality Control and Analytical Services.
Mr. Curtin has held executive management positions at Parke-Davis/Warner Lambert, King Pharmaceuticals, Graceway Pharmaceuticals, Rockward Pharmaceutical Consultants, Actient Pharmaceuticals and more recently Lynwood Pharmaceuticals. He has overseen the design, construction and validation of multiple pharmaceutical facilities and utility systems covering all dosage forms both in the US and OUS.
At King Pharmaceuticals Mr. Curtin was Executive Vice President Quality Operations and responsible for the Quality Operations of five US based manufacturing sites covering all dosage forms. And at Graceway Pharmaceuticals as Executive Vice President Technical Operations, he was responsible for all Quality, Supply Chain, Manufacturing and Engineering Operations for US, Canada and Mexico. This included oversight of seven Contract Manufacturing Organizations producing sterile, solid and semi-solid dosage forms at US and OUS sites.
"In my role as COO I look forward to enhancing UPM's presence and marketability in the CDMO space by utilizing the talents and technical skills of all our UPM colleagues to enhance systems, processes and capabilities," Mr. Curtin stated.
More at www.upm-inc.com
Mary Lee Schiesz
Manager of Marketing
Phone: +1 423 989 7057
SOURCE UPM Pharmaceuticals
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.